However, when miR-9 and miR-218 downregulated the expression of IL-6 and Janus kinase 2 (JAK2), they inhibited the activation of STAT3, leading to the downregulation of STAT3 expression and thus inhibiting the growth of tumor cells [111, 114, 115]. The gene discussed is IL6; the disease is neoplasm.